skip to main content

H.R. 4812 (116th): Ensuring Compliance Against Drug Diversion Act of 2020


The text of the bill below is as of Nov 16, 2020 (Reported by House Committee).


IB

Union Calendar No. 482

116th CONGRESS

2d Session

H. R. 4812

[Report No. 116–584, Part I]

IN THE HOUSE OF REPRESENTATIVES

October 23, 2019

introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

November 16, 2020

Additional sponsor: Mr. Walden


November 16, 2020

Reported from the Committee on Energy and Commerce

November 16, 2020

Committee on the Judiciary discharged; committed to the Committee of the Whole House on the State of the Union and ordered to be printed

A BILL

To amend the Controlled Substances Act to provide for the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances or list I chemicals, and for other purposes.


1.

Short title

This Act may be cited as the Ensuring Compliance Against Drug Diversion Act of 2019.

2.

Modification, transfer, and termination of registration To manufacture, distribute, or dispense controlled substances

Subsection (a) of section 302 of the Controlled Substances Act (21 U.S.C. 822) is amended by adding at the end the following new paragraph:

(3)
(A)

Except as provided in subparagraph (C), the registration of any registrant under this title to manufacture, distribute, or dispense controlled substances or list I chemicals terminates if and when such registrant—

(i)

dies;

(ii)

ceases legal existence;

(iii)

discontinues business or professional practice; or

(iv)

surrenders such registration.

(B)

In the case of such a registrant who ceases legal existence or discontinues business or professional practice, such registrant shall promptly notify the Attorney General in writing of such fact.

(C)

No registration under this title to manufacture, distribute, or dispense controlled substances or list I chemicals, and no authority conferred thereby, may be assigned or otherwise transferred except upon such conditions as the Attorney General may specify and then only pursuant to written consent. A registrant to whom a registration is assigned or transferred pursuant to the preceding sentence may not manufacture, distribute, or dispense controlled substances or list I chemicals pursuant to such registration until the Attorney General receives such written consent.

(D)

In the case of a registrant under this title to manufacture, distribute, or dispense controlled substances or list I chemicals desiring to discontinue business or professional practice altogether or with respect to controlled substances and list I chemicals (without assigning or transferring such business or professional practice to another entity), such registrant shall return to the Attorney General for cancellation—

(i)

the registrant’s certificate of registration;

(ii)

any unexecuted order forms in the registrant’s possession; and

(iii)

any other documentation that the Attorney General may require.

.

November 16, 2020

Reported from the Committee on Energy and Commerce

November 16, 2020

Committee on the Judiciary discharged; committed to the Committee of the Whole House on the State of the Union and ordered to be printed